Scienza Health today announced a strategic partnership with Samsung B2B Health to integrate the DigitalHumanOS™ platform with Samsung's purpose-built healthcare devices, creating a comprehensive ecosystem for AI-powered clinical automation secured by Samsung Knox enterprise platform.
The collaboration will deploy Scienza's nine specialized Digital Humans™ across Samsung's healthcare device portfolio, including tablets, smartphones, and interactive displays designed specifically for clinical environments. The integration leverages Samsung Knox's defense-grade security platform to ensure HIPAA compliance while enabling seamless voice-activated clinical workflows and patient interaction capabilities.
"Healthcare organizations lose $272 billion annually to inefficient workflows, and our partnership with Samsung addresses this crisis at the point of care," said David Kaiser, CEO of Scienza Health. "Samsung's innovative healthcare devices combined with Knox security provide the perfect foundation for our Digital Humans™ to transform how clinicians interact with patients while maintaining the highest security standards."
The partnership targets Samsung's growing B2B healthcare market, with devices specifically engineered for medical environments featuring antimicrobial coatings, drop resistance, and extended battery life optimized for 24/7 clinical operations. Early pilot deployments demonstrate 13 hours per week in saved documentation time while maintaining 94% diagnostic accuracy.
Samsung Knox's enterprise security framework provides multiple layers of protection including real-time kernel protection, secure boot verification, and encrypted storage—critical features for processing protected health information at the point of care. The platform's advanced threat detection capabilities continuously monitor for security anomalies while maintaining seamless user experience for healthcare professionals.
"The integration of Samsung's enterprise mobility solutions with Scienza's FDA-registered AI platform represents the future of intelligent healthcare," said Dr. George Mastorakos, Chief Medical AI Officer of Scienza Health. "Knox security ensures our Digital Humans™ can safely process patient data while delivering real-time clinical insights that improve both efficiency and patient outcomes."
Revolutionizing Point-of-Care AI Integration
The Samsung-Scienza partnership delivers enterprise-grade security and seamless AI integration across clinical environments:
- Samsung Knox defense-grade security platform ensures HIPAA compliance for protected health information
- Voice-activated Digital Humans™ integrated natively with Samsung healthcare tablets and smartphones
- Real-time speech biomarker analysis powered by Samsung's advanced processors and AI acceleration
- Antimicrobial device coatings and ruggedized design for 24/7 clinical environment operations
- Seamless workflow integration with existing EMR systems through Samsung's enterprise mobility platform
- Multi-language support across 78 languages for diverse patient populations
"Samsung's purpose-built healthcare devices provide the ideal platform for our Digital Humans™ to operate securely and efficiently in clinical environments. The Knox security framework gives healthcare organizations confidence that patient data remains protected while enabling unprecedented AI capabilities at the point of care."
— David Kaiser, CEO of Scienza Health
Strategic Ecosystem Partnerships
The Samsung partnership strengthens Scienza's comprehensive healthcare ecosystem:
- Samsung B2B Health: Integration and co-marketing agreement for purpose-built healthcare devices launching in Q2 2025
- Samsung Knox Enterprise Platform: Defense-grade security ensuring HIPAA compliance and threat protection
- Samsung Developer Program: Access to advanced SDK and hardware optimization tools for healthcare applications
- Global Device Deployment: International market expansion across Samsung's 190-country B2B healthcare network
Samsung's established healthcare relationships provide immediate access to enterprise customers, while their global supply chain ensures reliable device availability for rapid deployment across healthcare organizations worldwide.
Samsung healthcare devices will support deployment across multiple clinical specialties, with initial focus on emergency departments, primary care, and specialty clinics. The partnership targets 50,000 device deployments by end of 2025, supporting Scienza's goal of processing 100 million patient encounters annually.